NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
September 10, 2026 — Kaufman & Company launches BUILD 2030, a national initiative merging housing and AI infrastructure under one platform to drive coordinated development and community impact.
September 10, 2026 — SPARC AI launches Overwatch Patrol, a GPS-denied positioning app for soldiers, at MSPO. The cloud-based solution shares live positions without additional hardware.
September 10, 2026 — Quantum BioPharma receives FDA clearance for Phase 2 trial of Lucid-MS, a first-in-class myelin repair therapy for progressive MS. A potential game-changer.
September 10, 2026 — Quantum BioPharma advances Lucid-MS to phase 2 MS trial after FDA IND clearance. First-in-class PAD2 inhibitor could transform multiple sclerosis treatment.
September 10, 2026 — Coal prices rose last week on supply disruptions and firm demand, with Asian benchmarks above $120. Frontieras North America and TinyGems are highlighted.
September 10, 2026 — Quantum BioPharma gets FDA clearance for Phase 2 trial of Lucid-MS, a first-in-class MS drug targeting myelin repair, potentially transforming treatment.
September 10, 2026 — SS Innovations' SSi Mantra surgical robot reaches 14,103 procedures, 238 systems installed globally. FDA and CE mark decisions pending.
September 10, 2026 — TechForce Robotics, a Nightfood Holdings company, expands AI robotics strategy with RaaSP model and potential 5,000 robotic system deployment to tackle labor shortages.
September 10, 2026 — ESGold Corp. advances its Montauban Gold-Silver Project with new processing equipment, including a Falcon Gravity Concentrator and industrial thickeners, as it moves toward production in 2026.
September 10, 2026 — Rezolve Ai CEO Daniel Wagner to speak at H.C. Wainwright conference and host Investor Day on Oct 6 at Nasdaq, showcasing its AI-powered commerce platform.
September 10, 2026 — Onco-Innovations CMO Dr. Islam Mohamed discusses ONC010, a novel PNKP inhibitor with dual selectivity, and its promising preclinical results in cancer treatment.
September 10, 2026 — Quantum BioPharma's Lucid-MS advances to phase 2 MS trial after FDA IND clearance. Novel PAD2 inhibitor targets demyelination directly. Read more.
September 10, 2026 — American Fusion™ moves Texatron™ into active testing, achieving 100,000-atmosphere pressures. Harbinger updates coverage on AMFN's fusion progress and patents.
September 10, 2026 — Lahontan Gold hires Billy Choi as CFO, effective Oct 2026, to strengthen financial team ahead of Santa Fe Mine restart and 2027 production target.
September 10, 2026 — American Fusion's Texatron™ fusion program advances to active testing, achieving 100,000 atmospheres. Harbinger updates coverage on AMFN's progress.
September 10, 2026 — GeoVax Labs appeals Nasdaq delisting, reaffirms focus on GEO-MVA vaccine and Gedeptin® cancer therapy. Hearing set for October 13, 2026.
September 10, 2026 — The Gutter Pros highlights fall gutter installation and LeafBlaster Pro protection for Delmarva properties. Learn about signs of gutter damage and solutions.
September 10, 2026 — Insurance Canopy launches florist and plumbing insurance programs, offering same-day coverage and instant certificates of insurance online for small business owners.
September 10, 2026 — New York CityPASS now offers flexible choice of 5 from 10 attractions, adds Edge and Whitney, and lowers prices to $149 for adults. Save up to 51%.
September 10, 2026 — BioCorRx appoints Richard J. Baum, former Acting Director of White House ONDCP, to Strategic Advisory Board to advance addiction treatment and policy strategies.